Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin
以淋巴细胞计数、κ/λ比值或β2微球蛋白为指标评估elotuzumab治疗多发性骨髓瘤的疗效
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-32426-6
Shimazu, Yutaka; Kanda, Junya; Kosugi, Satoru; Ito, Tomoki; Kaneko, Hitomi; Imada, Kazunori; Shimura, Yuji; Fuchida, Shin-Ichi; Fukushima, Kentaro; Tanaka, Hirokazu; Yoshihara, Satoshi; Ohta, Kensuke; Uoshima, Nobuhiko; Yagi, Hideo; Shibayama, Hirohiko; Yamamura, Ryosuke; Tanaka, Yasuhiro; Uchiyama, Hitoji; Onda, Yoshiyuki; Adachi, Yoko; Hanamoto, Hitoshi; Takahashi, Ryoichi; Matsuda, Mitsuhiro; Miyoshi, Takashi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya
